Foreword, xi
Kim A. Eagle, MD

Preface, xii
Lawson Wulsin, MD, Michelle B. Riba, MD, MS, Melvyn Rubenfire, MD and Divy Ravindranath, MD, MS

1 The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease, 1
Willem J. Kop, PhD and John S. Gottdiener, MD

2 Depression and Cardiovascular Diseases, 18
Kevin B. Kerber, MD and Melvyn Rubenfire, MD

3 Depression, Anxiety, Anger, and Heart Failure, 34
Oliver G. Cameron, MD,PhD, Daniel Ehrmann and Bertram Pitt, MD

4 Cardiac Surgery, 49
Rima Styra, MD, Med, FRCPC, Christopher M. Feindel, MD and Marion E. McRae, RN, NP, MScN, CCRN-CSC-CMC, CCN, ACNP-BC

5 Cardiac Transplantation and Left Ventricular Assist Devices: Pre-Assessment and Post-Management, 62
Rachel Lipson Glick, MD, David Bradley S. Dyke, MD, Moira Kessler, BS, MD and Dayna J. LePlatte, MD

6 Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter-Defibrillators, 77
Divy Ravindranath, MD, MS and Frank Pelosi, MD

7 Pulmonary Arterial Hypertension: Psychosocial Implications and Treatment, 88
John M. Wryobeck, PhD and Melvyn Rubenfire, MD

8 Distinguishing Cardiac from Psychologic Somatic Symptoms, 99
Nicholas D. Giardino, PhD and Michael J. Shea, MD

9 Hypertrophic Cardiomopathy, 106
Moira Kessler, BS, MD, Sara Saberi, MD, Sharlene Day, MD, Tamara Gay, MD, Linda Baty, BSN and Edward Deneke, MD

10 Bipolar Disorder and Reducing Risk for Cardiovascular Disease, 116
Amy M. Kilbourne, PhD, MPH and David E. Goodrich, EdD

11 Sleep and Cardiovascular Disease, 135
Sanjaya Gupta, MD and J. Todd Arnedt, PhD

12 Posttraumatic Stress Disorder and Heart Disease, 153
Leonard A. Doerfler, PhD and John A. Paraskos, MD

13 Cardiovascular Manifestations of Panic and Anxiety, 165
Steven M. Schwartz, PhD, Oliver G. Cameron, MD, PhD and Melvyn Rubenfire, MD

14 Genetic Susceptibility and the Relationship between Cardiovascular Disease, Immunology, and Psychiatric Illness, 176
Sandra Villafuerte, PhD, Melvyn Rubenfire, MD and Ziad Kronfol, MD

15 Psychological Symptoms Associated with Cardiovascular Drugs; Cardiac Symptoms from Psychiatric Drugs; Drug Interactions, 194
Steven R. Erickson, Pharm D, Jolene R. Bostwick, Pharm D and Sally K. Guthrie, Pharm D

16 Exercise and Depression, 211
Barry A. Franklin, PhD, Justin E. Trivax, MD and Thomas E. Vanhecke, MD

17 Psychosocial Interventions: Meditation, 223
Elizabeth A.R. Robinson, PhD, MSW, MPH, Sandra M. Finkel, MPH and Elizabeth A. Jackson, MD, MPH

18 Smoking Cessation and Substance Use Modification in Cardiovascular Disease, 232
Gregory W. Dalack, MD and Elizabeth A. Jackson, MD, MPH

Appendix A: Selected Screening Tools and Research Instruments, 241

Appendix B: Berlin Questionnaire (for sleep apnea), 247

Index, 249